WASHINGTON–(BUSINESS WIRE)–#ADPD2023—Altoida, Inc., a precision neurology company pioneering non-invasive brain health measurement and neurological disease diagnostics with AI and augmented reality (AR), today announced two poster presentations at the upcoming AD/PD™ 2023 International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders, on March 28–April 1, 2023 in Gothenburg, Sweden.
Details of the presentations are as follows:
Poster Presentations
Poster Title: Characterization of Cognitive Domains in Individuals with MCI and AD Dementia with The Altoida Digital Neuro Signature (DNS)
Presenter: Alberto Ferrari, Ph.D., Biostatistician, Altoida
Poster Number: P0449* / #2273
Onsite Poster Board Number: 401
Poster Title: Evaluation of The Altoida Digital Neuro Signature (DNS) in Cognitively Normal and MCI Individuals with Hearing Loss – A Pilot Study
Presenter: Florencia Iulita, Ph.D., Head of Medical Strategy and Operations, Altoida
Poster Number: P0450* / #2128
Onsite Poster Board Number: 402
Poster category: A04.J. Imaging, Biomarkers, Diagnostics: Cognitive, Psychometric & Behavioral Tests, Digital Endpoints, Remote Testing
About Altoida, Inc.
Altoida is developing digital biomarkers of neurological disease with the power of augmented reality and machine learning all from a smart device. Our innovative AI-driven approach combines novel digital biomarkers with augmented reality to evaluate the brain while conducting immersive tasks. Altoida’s evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers. Altoida is based in Washington, DC. For more information, visit www.altoida.com or follow @Altoida on Twitter.
Contacts
Media
Kimberly Ha
KKH Advisors
917-291-5744
kimberly.ha@kkhadvisors.com
AI Nose and SLM SmellTech platform enter scale-up phase targeting robotics, automation, and environmental sensing…
Trusted by 150 leading brands globally, the agentic AI-powered platform converts third-party retail transactions into…
The Orlicki Group Champions Veterans' Homeownership Rights with Enhanced Education on VA Loan Benefits Amid…
Province's latest legislation aimed at fast‑tracking residential builds brings critical momentum for local home‑buyers -…
BODYWELLE details how Morpheus8 technology targets skin aging and laxity using FDA-cleared microneedling and RF…
~ Treatment to Evaluate Effect of Food on Overdose Protection of MPAR ~~ Grant Funds…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="450px" width="800px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
